SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
293.80    8.40 (2.94%)
Bid:
293.60
Ask:
294.20
Spread: 0.60 (0.204%)
Market Cap: £1.02b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Statement Re: Press Comment

20 Nov 2008 15:32

RNS Number : 6088I
Marwyn Materials Limited
20 November 2008
 



Marwyn Materials Limited ("Marwyn Materials")

STATEMENT REGARDING 

Ennstone PLC ("Ennstone")

Further to recent speculation, Marwyn Materials confirms that it has made an approach to the board of Ennstone in order to explore a possible transaction which may or may not be an offer. 

Shareholders should be aware that there is no certainty that any transaction will occur and a further announcement will be made as and when appropriate.

For the purposes of Rule 2.10 of the City Code on Takeovers and Mergers, Marwyn Materials confirms that it has 136,000,000 ordinary shares of no par value in issue at the close of business on 19 November 2008. The ISIN reference for these securities is JE00B2419D89.

Enquiries:

For further information, please contact:

Marwyn Materials Limited

Peter Tom

020 7389 6800

Simon Vivian

020 7389 6800

Collins Stewart Europe Limited (Nominated Adviser)

Stewart Wallace, Lorraine Delannoy

020 7523 8350

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Marwyn Materials or of Ennstone all dealings in any relevant securities of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Marwyn Materials or of Ennstone, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Marwyn Materials or of Ennstone by Marwyn Materials or Ennstone, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCFGMZMKGGGRZM
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.